Viewing Study NCT00598169

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2026-06-11 @ 12:04 AM
Study NCT ID: NCT00598169
Status: COMPLETED
Last Update Posted: 2020-08-10
First Post: 2008-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma
Sponsor: AIDS Malignancy Consortium
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AIDS-related diffuse large cell lymphoma View
None AIDS-related diffuse mixed cell lymphoma View
None AIDS-related diffuse small cleaved cell lymphoma View
None AIDS-related immunoblastic large cell lymphoma View
None AIDS-related lymphoblastic lymphoma View
None AIDS-related peripheral/systemic lymphoma View
None AIDS-related primary CNS lymphoma View
None AIDS-related small noncleaved cell lymphoma View